Analysis of the Effects of Oral Colostrum Administration in Premature Infants on the Breastfeeding (Oral colostrum)
Oral Colostrum Administration in Very Low Birth Weight Premature Infants
About this trial
This is an interventional supportive care trial for Oral Colostrum Administration in Very Low Birth Weight Premature Infants focused on measuring very low birth weight premature infants,, oral colostrum administration,, breastfeeding
Eligibility Criteria
İnclusive criteria
- Newborn's body weight between 1001-1500gr
- Newborn being premature (>28 and < 32 GW)
- Being admitted to the neonatal intensive care unit within the first 24 hours after birth
- Absence of congenital anomaly (craniofacial abnormality such as cleft palate, cleft lip, paralysis of facial muscles) in the newborn
- Absence of any diagnosed gastrointestinal, neurological and genetic disease (necrotizing enterocolitis, third and fourth level intracranial hemorrhage (ICH), periventricular leukomalacia, hydrocephalus, down syndrome, omphalocele, gastroschisis, short bowel syndrome and other diseases) in the newborn
- Absence of congenital heart disease requiring surgical treatment in the newborn
- Absence of Oral feeding of the newborn (Nasogastric/orogastric or trophic feeding can be done)
- Non-contraindication of the mother's milk to her infant
- Absence of the mother's diagnosed psychiatric story
- Mother's openness to communication and cooperation
- Mother's volunteering to participate in the study
- Bringing sufficient colostrum for administration by the mother
- Mother being literate
- Mother being primiparous and having single infant
- Mother's age above 18 years Exclusive criteria
- Newborn being SGA and LGA
- Mother's not coming to breastfeed her infant between two breastfeeding follow-ups
Sites / Locations
- sakarya University
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Experimental
Control Groups
In the first stage of data collection, the information in the "Mother-Preterm Introductory Information Form" study and control groups before colostrum administration, and the information in "Preterm Follow-up Form" including questions related to physiological parameters, body measurements and nutrition will be obtained. In the second stage, oral colostrum, will be administered once every 3 hours and for at least 5 days until the newborn begins oral feeding. In accordance with the oral colostrum protocol, a total of 0.2ml colostrum will be administered in approximately 1 minute for infants weighing between 1001-1500 g. The third stage, the effectiveness of the first breastfeeding will be evaluated by the observers in experimental group using the Bristol Breastfeeding Assessment Tool. In the last stage, one week after the first breastfeeding sucking / breastfeeding experience will be evaluated again.
The infants in the control group will be followed up by oral care with sterile physiological saline in routine care of the service